Host Defenses Against Zygomycetes
Open Access
- 1 February 2012
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 54 (suppl_1) , S61-S66
Abstract
Mucormycosis is a devastating disease and can occur in patients with a variety of risk factors, the most important of which are immunosuppression, anatomic barrier breakdown, iron overload, and hyperglycemia/acidosis. Similarly to what occurs with Aspergillus, the host stimulates an innate immune response against the challenging sporangiospores and invading hyphae of Zygomycetes. This article discusses the host defense to different Zygomycetes, its augmentation, and its subsequent impact on the outcome of mucormycosis.Keywords
This publication has 40 references indexed in Scilit:
- Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) DatabaseClinical Infectious Diseases, 2010
- Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006Emerging Infectious Diseases, 2009
- Outbreaks of zygomycosis in hospitalsClinical Microbiology and Infection, 2009
- Invasive zygomycosis in neonates and childrenClinical Microbiology and Infection, 2009
- The ecology of the Zygomycetes and its impact on environmental exposureClinical Microbiology and Infection, 2009
- Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?Clinical Microbiology and Infection, 2009
- Zygomycosis and diabetes mellitusClinical Microbiology and Infection, 2009
- Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defenceClinical Microbiology and Infection, 2006
- Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported CasesClinical Infectious Diseases, 2005
- Phagocytes and oxidative stressThe American Journal of Medicine, 2000